This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hammond, E. M. Articles by Giaccia, A. J. Search for Related Content PubMed PubMed Citation Articles by Hammond, E. M. Articles by Giaccia, A. J.

Inhibition of ATR Leads to Increased Sensitivity to Hypoxia/Reoxygenation

Center for Clinical Sciences Research, Department of Radiation Oncology, Stanford University, Stanford, California

The transient opening and closing of tumor vasculature result in periods of severe oxygen deprivation (hypoxia) followed by reoxygenation. This exerts a positive selective pressure for cells that have lost their sensitivity to killing by reduced oxygen levels. These cells are effectively resistant to hypoxia-induced apoptosis and conventional therapeutic approaches. Here we show hypoxia-induced S-phase arrest results in regions of single-stranded DNA in stalled replication forks and signals the activation of ATR. S-phase cells represent the most sensitive phase of the cell cycle to the stress of hypoxia/reoxygenation. Loss of ATR or inhibition of ATR kinase activity results in a further loss of reproductive viability in S-phase cells when exposed to hypoxic conditions followed by reoxygenation but has little effect on the inhibition of DNA synthesis. This is, at least in part, mediated via Chk1 signaling because loss of Chk1 also results in increased sensitivity to hypoxia/reoxygenation. The observed decrease in reproductive survival is in part because of the accumulation of DNA damage in S-phase cells during hypoxia exposure in the absence of full ATR activity. Therefore, ATR acts to protect stalled replication forks during hypoxia exposure. In conclusion, ATR and Chk1 play critical roles in the cellular response to hypoxia/reoxygenation, and inhibitors of ATR and Chk1 represent new hypoxic cell cytotoxins.

This article has been cited by other articles:

				I. M. Pires, Z. Bencokova, M. Milani, L. K. Folkes, J.-L. Li, M. R. Stratford, A. L. Harris, and E. M. Hammond Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic Instability Cancer Res., February 1, 2010; 70(3): 925 - 935. [Abstract] [Full Text] [PDF]

				Z. Bencokova, M. R. Kaufmann, I. M. Pires, P. S. Lecane, A. J. Giaccia, and E. M. Hammond ATM Activation and Signaling under Hypoxic Conditions Mol. Cell. Biol., January 15, 2009; 29(2): 526 - 537. [Abstract] [Full Text] [PDF]

				H. Lu, J. Yue, X. Meng, J. A. Nickoloff, and Z. Shen BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage Nucleic Acids Res., December 18, 2007; 35(21): 7160 - 7170. [Abstract] [Full Text] [PDF]

				H.-V. Nguyen, J.-L. Chen, J. Zhong, K.-J. Kim, E. D. Crandall, Z. Borok, Y. Chen, and D. K. Ann SUMOylation Attenuates Sensitivity toward Hypoxia- or Desferroxamine-Induced Injury by Modulating Adaptive Responses in Salivary Epithelial Cells Am. J. Pathol., May 1, 2006; 168(5): 1452 - 1463. [Abstract] [Full Text] [PDF]

				S. L. Gibson, R. S. Bindra, and P. M. Glazer Hypoxia-Induced Phosphorylation of Chk2 in an Ataxia Telangiectasia Mutated-Dependent Manner Cancer Res., December 1, 2005; 65(23): 10734 - 10741. [Abstract] [Full Text] [PDF]